September 1: The Week in Cancer News
Regulators reverse course on a plan to limit compensation for breast reconstruction surgery, and more news selected by the editors of Cancer Today.
Regulators reverse course on a plan to limit compensation for breast reconstruction surgery, and more news selected by the editors of Cancer Today.
In the span of a decade, the idea that tumor-derived molecules circulating in the bloodstream and other body fluids could be leveraged to reveal the presence of cancer and monitor its course has become...
“Administrative tasks” for cancer patients are linked to delayed or missed doctor visits, lab tests, prescriptions, and other services. Attempts by cancer patients to get more information about costs and health insurance coverage may...
Researchers find that lung cancer patients recovering from surgery are especially vulnerable to the health hazards of wildfires even up to a year later.
Study finds association between lorazepam use and poorer cancer outcomes, and weight-loss surgery linked to lower cancer risk in women.
Study suggests surgery leads to longer survival than radiation for non-small cell lung cancer, but radiation remains an important option.
A long and fruitful partnership in the world of cancer research began in 2006 in Hollywood with AACR CEO Margaret Foti, PhD, MD (hc), attending a meeting with Sherry Lansing, former chairman and CEO...
Radiation therapy is falling out of favor for some cancer types, and concerns grow about commercially available multi-cancer detection tests.
Lorazepam used to relieve stress may cause inflammation that promotes tumor growth and shortens progression-free survival, study says. A medication commonly used to ease the stress caused by cancer diagnosis and treatment may be...
The FDA approved a kit that allows for liver-directed delivery of the chemotherapy melphalan to treat metastatic liver disease from uveal melanoma. The U.S. Food and Drug Administration (FDA) has approved a kit for...